Yuting Yang
Impact in
-
- Sirtuins and Resveratrol in Medicine
-
- Phytochemicals and Antioxidant Activities
Papers in
-
- Ubiquitin and proteasome pathways 3
- Circular RNAs in diseases 2
- Angiogenesis and VEGF in Cancer 2
- RNA modifications and cancer 2
- RNA Interference and Gene Delivery 2
-
- Cancer, Lipids, and Metabolism 2
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Gang Fang (1 shared paper)Xueni Wang (1 shared paper)Yating An (1 shared paper)Juxiang Li (3 shared papers)Ling He (2 shared papers)Zhirong Zhang (2 shared papers)Jihong Wang (2 shared papers)Xingli Cun (2 shared papers)
- Journals
- European Journal of Pharmacology (2 papers)Redox Report (1 paper)Aging (1 paper)Acta Pharmaceutica Sinica B (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- China
In The Last Decade
Yuting Yang
17 papers receiving 443 citations
Peers
Comparison fields: 5 of 84
- Geriatrics and Gerontology 23
- Biochemistry 35
- Cancer Research 65
- Pharmaceutical Science 24
- Biomaterials 48
Countries citing papers authored by Yuting Yang
This map shows the geographic impact of Yuting Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuting Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuting Yang more than expected).
Fields of papers citing papers by Yuting Yang
This network shows the impact of papers produced by Yuting Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuting Yang. The network helps show where Yuting Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuting Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 153 | |
| 2 | 2020 | 67 | |
| 3 | 2018 | 45 | |
| 4 | 2022 | 39 | |
| 5 | 2016 | 29 | |
| 6 | 2021 | 26 | |
| 7 | 2023 | 22 | |
| 8 | 2018 | 18 | |
| 9 | 2020 | 12 | |
| 10 | 2023 | 8 | |
| 11 | 2024 | 7 | |
| 12 | 2021 | 5 | |
| 13 | 2024 | 4 | |
| 14 | 2022 | 4 | |
| 15 | 2023 | 3 | |
| 16 | 2018 | 2 | |
| 17 | 2025 | 2 |
About Yuting Yang
Yuting Yang is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Immunology, having authored 17 papers that have together received 446 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (3 papers), Cancer, Lipids, and Metabolism (2 papers), Ferroptosis and cancer prognosis (2 papers), Circular RNAs in diseases (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), RNA modifications and cancer (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Geriatrics and Gerontology (23 citations), Biochemistry (35 citations), Cancer Research (65 citations), Pharmaceutical Science (24 citations) and Biomaterials (48 citations). Yuting Yang has collaborated with scholars based in China. Frequent co-authors include Gang Fang, Xueni Wang, Yating An, Juxiang Li, Ling He, Zhirong Zhang, Jihong Wang, Xingli Cun, Qin He and Yingshu Wang. Their work appears in journals such as European Journal of Pharmacology, Redox Report, Aging, Acta Pharmaceutica Sinica B and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.